Posts
April 18 2015
HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) announced that it had entered into a definitive agreement to receive a $2.5 million investment from an affiliate of Mayne Pharma Group Limited (ASX: MYX). EG&S acted as counsel to HedgePath Pharmaceuticals.
April 17 2015
Catasys, Inc. announced the closing of their Bridge offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.
April 17 2015
Synthesis Energy Systems, Inc. announced the closing of their Registered Direct offering in the amount of $14,000,000. EG&S acted as counsel to the Placement Agent.
April 16 2015
EFactor Group Corp announced the acquisition of RocketHub Inc. in exchange for Efactor stock valued at an aggregate purchase price of $15 million. The acquisition was structured as a merger of a newly formed subsidiary of EFactor with and into RocketHub, where RocketHub survived the merger as a wholly-owned subsidiary of EFactor. EG&S acted as counsel to EFactor.
April 08 2015
Staffing 360 Solutions, Inc. announced the entry into a $25 million revolving credit facility and $3 million term loan with MidCap Financial. EG&S acted as counsel to Staffing.
April 06 2015
XTL Biopharmaceuticals Ltd. announced the closing of their Registered Direct offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.
April 06 2015
Inventergy, Inc. announced the closing of their Registered Direct offering in the amount of $2,150,000. EG&S acted as counsel to the Company.
April 03 2015
Vapir Enterprises Inc. announced the closing of their PIPE offering in the amount of $500,000. EG&S acted as counsel to the Investor.